BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2192581)

  • 1. A turbidimetric method for measuring fibrin formation and fibrinolysis at solid-liquid interfaces.
    Retzinger GS; McGinnis MC
    Anal Biochem; 1990 Apr; 186(1):169-78. PubMed ID: 2192581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A turbidimetric assay for quantitating functional fibrin(ogen) using polystyrene-divinylbenzene microparticles.
    Cook BC
    Anal Biochem; 1999 May; 270(1):83-7. PubMed ID: 10328768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A turbidimetric method for measuring the activity of trypsin and its inhibition.
    Walker MB; Retzinger AC; Retzinger GS
    Anal Biochem; 2006 Apr; 351(1):114-21. PubMed ID: 16388777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexation with heparin prevents adhesion between fibrin-coated surfaces.
    Retzinger GS; Chandler LJ; Cook BC
    J Biol Chem; 1992 Dec; 267(34):24356-62. PubMed ID: 1447186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of plasma factor XIIIa activity using fibrin-coated microscopic latex beads.
    Retzinger GS; Cook BC; Smith RE; McGinnis MC
    Anal Biochem; 1991 May; 195(1):18-23. PubMed ID: 1679613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of human platelets with immobilized fibrinogen is dictated by the chemical character of the surface.
    Cook BC
    Thromb Res; 2001 Oct; 104(1):39-48. PubMed ID: 11583737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
    Jones AJ; Meunier AM
    Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unstimulated and thrombin-stimulated platelets binding to immobilized fibrinogen and fibrin on polystyrene supports.
    Martínez-Sales V; Vila V; Réganon E; Aznar J
    Haemostasis; 1995; 25(4):158-65. PubMed ID: 7557654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of human fibrinogen and fibrin in vitro. Its consequences on the properties of fibrin(ogen).
    Mirshahi M; Soria J; Soria C; Bertrand O; Mirshahi M; Basdevant A
    Thromb Res; 1987 Nov; 48(3):279-89. PubMed ID: 3124289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin. (II) Application of enzyme kinetics to turbidimetrical method.
    Sato H; Nakajima A
    Thromb Res; 1984 Jul; 35(2):133-9. PubMed ID: 6474414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of fibrin structure on fibrinolysis.
    Gabriel DA; Muga K; Boothroyd EM
    J Biol Chem; 1992 Dec; 267(34):24259-63. PubMed ID: 1447176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The course and prerequisites of Lys-plasminogen formation during fibrinolysis.
    Suenson E; Thorsen S
    Biochemistry; 1988 Apr; 27(7):2435-43. PubMed ID: 3382632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the role of in vivo proteolysis (fibrinogenolysis) in prolonging the thrombin time of human umbilical cord fibrinogen.
    Galanakis DK; Mosesson MW
    Blood; 1976 Jul; 48(1):109-18. PubMed ID: 947399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Turbidimetric analysis of fibrin polymerization in the plasma].
    Shcherbak IG; Subbotina TF; Faenkova VP; Riumina EV
    Vopr Med Khim; 2001; 47(1):80-90. PubMed ID: 11386001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
    Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
    Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen assay by means of the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.